LEARNLIGHT UK LIMITED

1. Financial Health Score: B (Stable, but requires further internal examination)

Explanation: Based on the available corporate vitals, Learnlight UK Limited presents as a structurally stable, long-standing entity with no signs of administrative distress or regulatory infection. However, because the company files under the "Small" category, detailed financial blood work (profit & loss figures, cash flow statements) is not publicly dispensed, meaning a full deep-tissue financial diagnosis is limited. The score of B reflects robust operational health and compliance, tempered by the necessity to look beneath the surface to confirm true profitability and liquidity.

2. Key Vital Signs

• Corporate Heartbeat (Filing Compliance): Strong and Regular. The company's accounts are up to date (last made up to 31 Dec 2024) and not overdue. Its confirmation statement is also current. This indicates a healthy, disciplined administrative pulse with no signs of regulatory fatigue.
• Corporate Lifespan (Incorporation Date): Excellent. Incorporated in 1996, the business has a nearly 30-year track record. It has survived multiple economic "flu seasons" (recessions, pandemics), indicating strong underlying resilience and adaptive immunity.
• Genetic Makeup (Ownership & Control): Consolidated. Learnlight Holdings Limited owns more than 75% of the shares, making the UK entity a subsidiary of a larger corporate parent. This means the subsidiary's financial health is intrinsically linked to the "parent donor"—if the parent catches a cold, the subsidiary will likely sneeze.
• Blood Volume (Share Capital): Nominal. The issued share capital is a mere £25. While this is a standard legal minimum for UK limited companies, it means the company relies entirely on retained earnings, operational cash flow, or intercompany transfusions (from the parent) to fund its operations.
• Cellular Structure (Leadership): Active and Specialized. The board includes a dedicated Finance Director (Gregorio Cabeza Lopez De Sagredo), which suggests the company's financial nervous system is being actively monitored and managed.

3. Diagnosis & Prognosis

Symptoms Analysis: The most notable "surgical scar" on the corporate record is the name change in 2019 from Communicaid Group Limited to Learnlight UK Limited. Rather than a symptom of distress, this is typically a sign of healthy evolution—a rebranding to align with their current market positioning as an AI-powered EdTech provider.

Because the company falls within the "Small" thresholds, it benefits from a reduced filing diet, meaning it is only required to file an abbreviated balance sheet. Consequently, we cannot observe the traditional vital signs of turnover, gross margin, or net profit. We can only see the structural shell. The absence of any "distress symptoms"—such as overdue filings, director disqualifications, liquidation flags, or changes in registered address—suggests the underlying business is not in acute distress.

Prognosis (Future Outlook): The prognosis is cautiously optimistic. Operating in the post-secondary education and corporate training sector (SIC 85410), the company has successfully pivoted its brand to incorporate AI and digital delivery, which is where the industry's lifeblood currently flows. However, as a subsidiary heavily controlled by a parent entity, its future health is heavily dependent on the strategic decisions and financial stability of Learnlight Holdings Limited. If the parent company remains healthy, this UK subsidiary should continue to thrive.

4. Recommendations

To ensure continued financial wellness and build a stronger immune system against market volatility, the following preventative measures are recommended:

• Conduct a Full Internal Blood Panel: While abbreviated accounts are legally sufficient for a small company, management should regularly review full management accounts, cash flow forecasts, and KPIs internally to ensure the business is maintaining healthy liquidity.
• Monitor Parent-Subsidiary Contagion Risk: Given that Learnlight Holdings Limited holds controlling interest, the UK directors must stay appraised of the parent company's financial health. Financial distress at the holding company level can quickly drain the subsidiary's resources through "upstream" cash sweeps or restricted funding.
• Strengthen Working Capital Reserves: With a nominal share capital of £25, the business relies on trading profits or parent backing. Ensure that the "working capital" (current assets minus current liabilities) remains robust to avoid the need for emergency financial transfusions.
• Review Intercompany Balances: If the UK entity owes money to (or is owed money by) its parent or sister companies, these intercompany balances should be closely monitored. Prolonged creditor balances with the parent could indicate cash flow pressure, while prolonged debtor balances could indicate an inefficient capital structure.